Stryker launches Citrefix™ Suture Anchor System, featuring award-winning Citregen biomaterial designed to support bone regeneration and the natural healing process
At AANA 2019, Stryker hosts a lunch-and-learn presentation featuring a new surgical planning and execution platform designed to enhance efficiency and patient experience for hip arthroscopy
Stryker crosses the 95% thresholds in VEXIM and announces its intention to file a proposed public buy-out offer followed by a squeeze-out for the outstanding shares of VEXIM
Stryker’s DAWN Trial results contribute to updated acute ischemic stroke guidelines from the American Heart Association and American Stroke Association
Stryker Orthopaedics to compensate additional eligible U.S. patients who had surgery to replace their Rejuvenate Modular-Neck and/or ABG II Modular-Neck Hip Stems